CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS
April 09, 2020 19:17 ET
|
Champignon Brands Inc.
VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company...
Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms
April 03, 2020 08:30 ET
|
Champignon Brands Inc.
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Champignon Brands Inc. (OTC:SHRMF) (CSE:SHRM) announces the availability of a broadcast titled, “Medical Mushroom Companies Expand...
Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine
April 01, 2020 08:30 ET
|
Champignon Brands Inc.
NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Champignon Brands Inc. (OTC:SHRMF) (CSE:SHRM) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one...
Champignon nomme un pharmacognosiste et conseiller clinique de l’Université de Toronto sur son comité consultatif spécial
March 31, 2020 08:25 ET
|
Champignon Brands Inc.
VANCOUVER, Colombie-Britannique, 31 mars 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : SHRMF), une société des sciences de...
REPEAT - CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
March 31, 2020 08:00 ET
|
Champignon Brands Inc.
VANCOUVER, British Columbia, March 31, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company...
CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
March 31, 2020 03:05 ET
|
Champignon Brands Inc.
VANCOUVER, British Columbia, March 31, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company...
RAPPEL - Champignon Brands élargit son portefeuille d’études précliniques grâce à des études mesurées de dosage de psilocybine à l’Université de Miami
March 30, 2020 08:00 ET
|
Champignon Brands Inc.
VANCOUVER, Colombie-Britannique, 30 mars 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : SHRMF), une entreprise axée sur le...
REPEAT - CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
March 30, 2020 08:00 ET
|
Champignon Brands Inc.
VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a health and wellness company specializing...
Champignon Brands élargit son portefeuille d’études précliniques grâce à des études mesurées de dosage de psilocybine à l’Université de Miami
March 27, 2020 16:05 ET
|
Champignon Brands Inc.
VANCOUVER, Colombie-Britannique, 27 mars 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : SHRMF), une entreprise axée sur le...
CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
March 27, 2020 16:05 ET
|
Champignon Brands Inc.
VANCOUVER, British Columbia, March 27, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a health and wellness company specializing...